Literature DB >> 4883585

A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction.

R H Gifford, A R Feinstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4883585     DOI: 10.1056/NEJM196902132800703

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  21 in total

Review 1.  Clinical trials and clinical practice in the elderly. A focus on hypertension.

Authors:  M E Kitler
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

Review 2.  Anticoagulation and the heart.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

3.  Corticosteroids in stable chronic obstructive pulmonary disease: reappraisal of efficacy.

Authors:  J K Stoller; Z B Gerbarg; A R Feinstein
Journal:  J Gen Intern Med       Date:  1987 Jan-Feb       Impact factor: 5.128

4.  Is the clinical trial evidence about new drugs statistically adequate?

Authors:  J M Bland; D R Jones; S Bennett; D G Cook; A P Haines; A J MacFarlane
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

5.  Streptokinase.

Authors: 
Journal:  Br Med J       Date:  1977-04-09

6.  Indications for oral anticoagulant treatment.

Authors:  A S Gallus
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

7.  Oral anticoagulants--the totem and the taboo.

Authors:  A Breckenridge
Journal:  Br Med J       Date:  1976-02-21

Review 8.  Do coronary artery bypass operations prolong life?

Authors:  K W Carr; R L Engler; J Ross
Journal:  West J Med       Date:  1982-04

9.  [Low-dose acetylsalicylic acid (100 mg/day) following aortocoronary bypass operation].

Authors:  M Weber; C von Schacky; R Lorenz; W Meister; J Kotzur; B Reichart; K Theisen; P C Weber
Journal:  Klin Wochenschr       Date:  1984-05-15

Review 10.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.